Holen Sie sich die Stockscreener-App
5.915
1.90%
0.125
Schlusskurs vom Vortag:
$5.79
Offen:
$5.79
24-Stunden-Volumen:
163.17K
Relative Volume:
0.65
Marktkapitalisierung:
$304.17M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-197.68M
KGV:
-1.0377
EPS:
-5.7
Netto-Cashflow:
$-158.88M
1W Leistung:
+11.32%
1M Leistung:
+60.76%
6M Leistung:
+83.80%
1J Leistung:
+162.22%
1-Tages-Spanne:
$5.66
$5.93
1-Wochen-Bereich:
$5.08
$6.00
52-Wochen-Spanne:
$2.185
$7.77
Kodiak Sciences Inc Stock (KOD) Company Profile
Firmenname
Kodiak Sciences Inc
Sektor
Branche
Telefon
650-281-0850
Adresse
1200 PAGE MILL RD, PALO ALTO, CA
Vergleichen Sie KOD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| KOD | 5.915 | 304.17M | 0 | -197.68M | -158.88M | -5.70 |
| VRTX | 450.37 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 747.10 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 591.88 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.29 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 107.52 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-05 | Eingeleitet | H.C. Wainwright | Neutral |
| 2023-12-11 | Fortgesetzt | Goldman | Sell |
| 2023-11-17 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2023-07-27 | Herabstufung | UBS | Buy → Neutral |
| 2023-07-25 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2023-07-25 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-07-24 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2023-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2022-11-15 | Eingeleitet | CapitalOne | Overweight |
| 2022-08-02 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-02-24 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-05-11 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2021-03-12 | Eingeleitet | Evercore ISI | Outperform |
| 2021-03-01 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2021-02-17 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2021-01-25 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-12-16 | Eingeleitet | UBS | Buy |
| 2020-12-11 | Eingeleitet | Citigroup | Neutral |
| 2020-11-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-11-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-13 | Herabstufung | Goldman | Buy → Neutral |
| 2020-03-31 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-03-03 | Eingeleitet | Goldman | Buy |
| 2020-02-18 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-02-06 | Eingeleitet | SunTrust | Buy |
| 2020-01-08 | Eingeleitet | ROTH Capital | Buy |
| 2020-01-03 | Eingeleitet | Jefferies | Buy |
| 2019-12-24 | Eingeleitet | JP Morgan | Overweight |
| 2019-10-15 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-02-20 | Eingeleitet | Chardan Capital Markets | Buy |
| 2018-10-29 | Eingeleitet | Barclays | Overweight |
| 2018-10-29 | Eingeleitet | BofA/Merrill | Buy |
| 2018-10-29 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Kodiak Sciences Inc Aktie (KOD) Neueste Nachrichten
Kodiak Q3 Loss Narrower Than Expected, Pipeline Development in Focus - MSN
GSA Capital Partners LLP Makes New Investment in Kodiak Sciences Inc. (NASDAQ:KOD) - MarketBeat
Kodiak: Tarcocimab Faces High Barriers To Entry Despite Resurrection (Rating Upgrade) - Seeking Alpha
Kodiak Sciences (NASDAQ:KOD) Given New $4.00 Price Target at Barclays - MarketBeat
Kodiak Sciences Inc (KOD) Quarterly 10-Q Report - Quartzy
Kodiak Sciences: Drug Shows 3x Longer Half-Life, Reports $43.9M Q3 Loss | KOD Stock News - StockTitan
Diabetic Retinopathy Clinical Trials 2024: FDA Approvals, - openPR
Kodiak Sciences to Present at Two Major Healthcare Investor Conferences | KOD Stock News - StockTitan
Report Finds Big Disparities in Americans' Well-Being by Region - 69News WFMZ-TV
Weight Loss Meds Help Stroke Survivors Prevent Stroke Recurrence, Death - 69News WFMZ-TV
Diabetes & Kidney Trouble Can Bring Heart Disease Decades Earlier - 69News WFMZ-TV
Hourglass-Shaped Stent Might Ease Tough-to-Treat Angina - 69News WFMZ-TV
Bystanders More Readily Perform CPR If 911 Operator Instructs - 69News WFMZ-TV
How ADHD May Influence a Child's Weight - 69News WFMZ-TV
Have an Implanted Defibrillator? Triple-Digit Heatwaves Could Pose Danger - 69News WFMZ-TV
Obesity-Linked Heart Deaths Nearly Tripled in U.S. Over Past Two Decades - 69News WFMZ-TV
Empowering Growth: Diabetic Macular Edema Market 2024 - openPR
Age-Related Macular Degeneration Market Size in the 7MM is expected to Grow by 2034, estimates DelveInsight - Barchart
Bow-legged girl 14 cm taller after life-changing surgery - 69News WFMZ-TV
Kodiak Sciences (KOD) Price Target Increased by 25.00% to 5.10 - MSN
Zacks Research Raises Earnings Estimates for Kodiak Sciences - MarketBeat
Age-related Macular Degeneration Market Size is Set for Rapid - openPR
Sanctuary Advisors LLC Purchases New Holdings in Denny’s Co. (NASDAQ:DENN) - Defense World
3 US Penny Stocks With Market Caps Under $500M To Consider - Simply Wall St
Financial Comparison: Kodiak Sciences (NASDAQ:KOD) & Fennec Pharmaceuticals (NASDAQ:FENC) - Defense World
Wet Age-Related Macular Degeneration Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - The Globe and Mail
Kodiak Sciences Inc. (NASDAQ:KOD) Short Interest Update - MarketBeat
Pacific Seafood to take over Trident Seafoods’ Kodiak operations - just-food.com
Campaigning begins for Japan's parliamentary election - 69News WFMZ-TV
KODKodiak Sciences Inc Latest Stock News & Market Updates - StockTitan
Kodiak Sciences to Present at Innovate Retina 2024 - cnhinews.com
Retinal Vein Occlusion Market Size is Set for Rapid Growth as - openPR
How early is too early to prep for Thanksgiving? - 69News WFMZ-TV
Expect employers to get more picky about who you see for care - 69News WFMZ-TV
Documents show OpenAI's long journey from nonprofit to $157B valued company - 69News WFMZ-TV
Could Certain Genes Help You Slim Down? - 69News WFMZ-TV
Kodiak Counts on Tarcocimab Eye Disease Program Despite Setbacks - Yahoo Finance
Having COVID-19 doubles risk of heart attack or stroke: study - 69News WFMZ-TV
VEGFR-2 Antagonists Clinical Trial Pipeline Insights Featuring 25+ Companies | DelveInsight - GlobeNewswire
Innovator U.S. Equity Accelerated 9 Buffer ETF – January (BATS:XBJA) Shares Sold by Cetera Investment Advisers - Defense World
Vanguard Personalized Indexing Management LLC Buys Shares of 17,896 Redfin Co. (NASDAQ:RDFN) - Defense World
Natural Grocers by Vitamin Cottage (NYSE:NGVC) Stock Price Up 4.8% - Defense World
Susquehanna Portfolio Strategies LLC Has $330,000 Stake in SandRidge Energy, Inc. (NYSE:SD) - Defense World
Kodiak Sciences' SWOT analysis: biotech stock faces pivotal year ahead By Investing.com - Investing.com South Africa
Xponance Inc. Sells 12,667 Shares of Mattel, Inc. (NASDAQ:MAT) - Defense World
Inozyme Pharma (NASDAQ:INZY) Earns Outperform Rating from Wedbush - Defense World
Retinal Disorder Treatment Market Share Report, Industry Share and Trends Analysis By 2033 - WhaTech
Data Storage (NASDAQ:DTST) Stock Quotes, Forecast and News Summary - Benzinga
Evergreen Capital Management LLC Raises Position in Hannon Armstrong Sustainable Infrastructure Capital, Inc. (NYSE:HASI) - Defense World
Retinal Biologics Market Advancements Highlighted by Size, Share Analysis And Forecast Report 2024 To 2033 - WhaTech
Goldman Sachs maintains sell rating on Kodiak Sciences stock By Investing.com - Investing.com South Africa
Finanzdaten der Kodiak Sciences Inc-Aktie (KOD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Kodiak Sciences Inc-Aktie (KOD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BORGESON JOHN A. | See Remarks |
Jun 12 '24 |
Sale |
2.92 |
1,558 |
4,549 |
179,544 |
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):